COVID-related Vanishing Bile Duct Syndrome (VBDS).
作者信息
Russe-Russe Jose R, Liu Li, Thuluvath Paul J
机构信息
Department of Medicine, Mercy Medical Center, Baltimore MD, USA.
Department of Pathology, Mercy Medical Center, Baltimore MD, USA.
出版信息
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101302. doi: 10.1016/j.jceh.2023.11.002. Epub 2023 Nov 7.
Abstract
摘要
相似文献
1
COVID-related Vanishing Bile Duct Syndrome (VBDS).新型冠状病毒肺炎相关的小胆管消失综合征（VBDS）。
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101302. doi: 10.1016/j.jceh.2023.11.002. Epub 2023 Nov 7.
2
Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma.一名复发性霍奇金淋巴瘤患者的胆管消失综合征
J Med Cases. 2023 May;14(5):162-168. doi: 10.14740/jmc4073. Epub 2023 May 31.
3
Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.霍奇金淋巴瘤中的胆管消失综合征：一例报告及文献复习
World J Gastroenterol. 2017 Jan 14;23(2):366-372. doi: 10.3748/wjg.v23.i2.366.
4
Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.类固醇治疗消失性胆管综合征伴急性肾小管坏死患者一例。
Intern Med. 2024 Jan 1;63(1):57-61. doi: 10.2169/internalmedicine.1826-23. Epub 2023 May 10.
5
Vanishing Bile Duct Syndrome: A Differential Diagnosis for Painless Jaundice.消失胆管综合征：无痛性黄疸的鉴别诊断
Cureus. 2024 Sep 5;16(9):e68724. doi: 10.7759/cureus.68724. eCollection 2024 Sep.
6
Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.霍奇金淋巴瘤患者发生消失性胆管综合征，尽管淋巴瘤缓解但仍导致死亡。
Saudi J Gastroenterol. 2013 Nov-Dec;19(6):286-9. doi: 10.4103/1319-3767.121037.
7
[Clinicopathologic features of drug-induced vanishing bile duct syndrome].[药物性胆汁淤积性胆管消失综合征的临床病理特征]
Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):317-320. doi: 10.3760/cma.j.issn.1007-3418.2017.04.019.
8
Meropenem-induced vanishing bile duct syndrome.美罗培南致胆汁消失综合征。
Pharmacotherapy. 2010 Sep;30(9):953. doi: 10.1592/phco.30.9.953.
9
Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.一名成年患者布洛芬治疗后出现伴有高脂血症的消失胆管综合征：病例报告
BMC Gastroenterol. 2018 Sep 29;18(1):142. doi: 10.1186/s12876-018-0869-9.
10
Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis.
Expert Opin Drug Saf. 2024 Oct 16:1-7. doi: 10.1080/14740338.2024.2416537.
本文引用的文献
1
Post-COVID-19 Cholangiopathy: A Systematic Review.新冠病毒感染后胆管病：一项系统综述
J Clin Exp Hepatol. 2023 May-Jun;13(3):489-499. doi: 10.1016/j.jceh.2022.10.009. Epub 2022 Oct 30.
2
Post-COVID-19 Cholestasis: A Case Series and Review of Literature.新冠后胆汁淤积：病例系列及文献综述
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1580-1590. doi: 10.1016/j.jceh.2022.06.004. Epub 2022 Jun 11.
3
Post-COVID-19 Cholangiopathy: A Novel Entity.新冠病毒感染相关胆管病：一种新的疾病实体。
Am J Gastroenterol. 2021 May 1;116(5):1077-1082. doi: 10.14309/ajg.0000000000001154.
4
Structure analysis of the receptor binding of 2019-nCoV.2019新型冠状病毒受体结合的结构分析
Biochem Biophys Res Commun. 2020 Feb 17;525(1):135-40. doi: 10.1016/j.bbrc.2020.02.071.
5
A Case of mild idiopathic adulthood ductopenia and brief review of literature.一例轻度特发性成人胆管减少症，并简要复习文献。
Gastroenterol Rep (Oxf). 2015 May;3(2):167-9. doi: 10.1093/gastro/gou048. Epub 2014 Jul 16.
Zotero 插件